Loading…
Attending this event?
View analytic
Wednesday, June 21 • 4:00pm - 5:15pm
#374: Global Perspective on ICH: Part 2 of 2

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Forum
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-17-532-L04-P; CME 1.25; IACET 1.25; RN 1.25

This forum will provide an overview of the ICH association and offer insight into strategic, long-term views on advancing global convergence of regulatory science through ICH, including important enablers such as stakeholder partnerships and greater connection to other harmonization initiatives. A panel of experts will discuss the benefits of ICH and global regulatory harmonization, including views on key strategic topics that will enhance simultaneous global drug development.

Learning Objectives

Discuss what the ICH reforms mean for global development as ICH moves toward being a truly global platform for international harmonization; Describe ICH's connection to other global harmonization/convergence forums; Identify the value and benefits of global regulatory harmonization and the ICH; Discuss opportunities to advance regulatory science through ICH.

Chair

Patrick K Brady, PharmD

Speaker

Fostering Simultaneous Global Development via Regulatory Harmonization and ICH Reforms
Camille Jackson

Partnership and Global Connectivity After ICH's Reform: New Opportunities for Global Regulatory Harmonization and Advancing Regulatory Science
Jerry Stewart, JD, MS, RPh

Panelist
Lawrence Eugene Liberti, MS, RPh, RAC



Moderators
avatar for Patrick Brady

Patrick Brady

Regulatory Policy and Intelligence, Bayer
Dr. Patrick Brady is Vice President, Regulatory Affairs at Bayer. In this role, he leads Bayer’s global regulatory policy and intelligence activities. He has more than 10 years of experience in Regulatory Affairs. Prior to joining Bayer, Patrick led international science and re... Read More →

Speakers
avatar for Patrick Brady

Patrick Brady

Regulatory Policy and Intelligence, Bayer
Dr. Patrick Brady is Vice President, Regulatory Affairs at Bayer. In this role, he leads Bayer’s global regulatory policy and intelligence activities. He has more than 10 years of experience in Regulatory Affairs. Prior to joining Bayer, Patrick led international science and re... Read More →
CJ

Camille Jackson

Senior Director, Science and Regulatory Advocacy, Pharmaceutical Research and Manufacturers of America (PhRMA)
avatar for Lawrence Liberti

Lawrence Liberti

Executive Director, Centre For Innovation In Regulatory Science (CIRS)
For the past 37 years, Mr Liberti has worked in the fields of regulatory affairs and clinical R&D. Since 2009 he has served as the Executive Director of CIRS (formerly the CMR International Institute for Regulatory Science), an independent, division of Clarivate Analytics. He is... Read More →
avatar for Jerry Stewart

Jerry Stewart

Deputy Vice President, Scientific and Regulatory Advocacy, Pharmaceutical Research and Manufacturers of America (PhRMA)
Mr. Jerry Stewart, JD, MS, RPh, is Deputy Vice President at the Pharmaceutical Research and Manufacturers of America (PhRMA), located in Washington, DC, USA. He is responsible for international regulatory science policy and advocacy, and the global pharmaceutical manufacturing an... Read More →


Wednesday June 21, 2017 4:00pm - 5:15pm
N228 McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616